Uncategorized Archives

Drinks With The Deal: Bok on How Wall Street Is Like 'Glengarry Glen Ross'

By David Marcus

Published: August 14th, 2025

Scott Bok, the former chairman and CEO of M&A boutique Greenhill, discusses his career, his new memoir and the challenges of managing the highly ambitious people in finance.

Private Briefing: Salesforce Partners Attract Sponsors, Strategics

By Chris Nolter

Published: June 30th, 2025

Houlihan Lokey's R.B. McCutcheon breaks down the field of more than 3,400 consultants, MSPs and other partners that help clients maximize Salesforce tools.

Popping the AI Hyperbole Bubble

By David Marcus

Published: October 1st, 2024

In their new book 'AI Snake Oil,' Princeton professor Arvind Narayanan and former Facebook engineer Sayash Kapoor suggest that the use of AI in the workplace will be more evolutionary than revolutionary.

Private Cos.

Environmental Consultancy EI Group Grows Where Clients Go

By Huzair Latif

Published: February 28th, 2024

M&A

Chesapeake Buys Chief Oil, Sells Wyoming

By Tom Terrarosa

Published: February 1st, 2022

Scoops & Exclusives

Wellness Targets Line Big Food's Shopping List

By Nikitha Sattiraju

Published: January 25th, 2022

As food and beverage giants gobble up better-for-you brands to meet changing consumer preferences, companies such as Instagram-famous supplements maker Ritual and chickpea snack brand Hippeas are among the next likely batch of targets.

Movers & Shakers: Lim Rejoins Kirkland, Hogan Builds LatAm Expertise

By Michael Brown

Published: January 14th, 2022

Kirkland & Ellis welcomes back debt finance lawyer Fred Lim from Goodwin Procter while Hogan Lovells adds Richard Puttré in its Latin American project finance team from Jones Day.

Webcast: PIPEs Gain Popularity Amid Pandemic

Published: August 19th, 2020

The Deal and the panel of experts discuss the revival of the PIPE market, its steady growth and trends for 2020 and beyond.

Webcast: Pills and CEOs Under Fire as M&A Fades

Published: August 10th, 2020

The Deal and its expert panel discuss increased scrutiny on executive pay, poison pills and other measures taken to defend against activist campaigns.

Insights & Analysis